Delicious - So Jazzy's essentially mirthful and of little, too no consequence.
Thank you.
Agree >> lack of credulity, seconded.
***
Portentous timing...
The Arrival of the (If I may be so bold) supposedly "white-knight" of scam blasting. Or is that a "cover?"
We've endured so many obstacles, you might >>> possibly <<< be the latest.
But...
Finally, we have a leader who "knows" Leronlimab and is steering a course, some Pharma entities might find threatening to "drug line-ups."
Further, a serious cash settlement might re- ignite CytoDyn/Leronlimab's progress...and to some>> that's "VERY NAUGHTY."
And behold
"Poof" a flash of light
and
Janice arrives.
(To me the BIG question is >> Are you looking for some outrageous scam or creating barriers to benefit BP?")
So
Please investigate!
Peek under every rock and log, but don't forget to look "without" (outside). You'll eventually discover >> this isn't some crazy scam to defraud investors of their hard-earned cash. But Leronlimab is a drug with usages (with minimal reported side-effects) that should be "brought to the fore!"
In fact, you might discover the "real workings of the beast." Big Pharma works for Big Pharma - its all about wealth first, and somewhere the public good comes in... waaay... farther down the list.
For that reason, Leronlimab has been embattled every step of the way.
If I'm partially accurate >>you and I are (To be polite) older folk. The days of youth are (regrettably) in the rear view mirror. At this point in our lives, our bodies are not the "well;oiled machines" of our thirties. We are prone to some dysregulation and points of chronic inflammation. Beside Leronlimab's modulation of the CCR5 receptor, its ability to modulate some key immunological processes, suggests its ability to help deal with inflammatory "situations." And it can "cross" the blood-brain Barrrier. Wow.
There's some serous reasons that Leronlimab is "scary." to BP >> But (no this is not a magic potion), it won't cure everything, but (from those utilizing it) appears to have minimal and/or only short term side effects, but amazingly useful.
While loved ones slip into decline, it's frustrating (a mild word) when leronlimab, the drug, with the potential to halt or reverse that descent, is at hand, but inaccessible.*
And perhaps Jazzy might look significantly smarter in motley, LOL.
